Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms
Related Experiment Video
Updated: Feb 14, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Christopher H Douse1, Stuart Bloor2, Yangci Liu3
1Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0QH, UK. cdouse@mrc-lmb.cam.ac.uk.
Abstract:
Missense mutations in MORC2 cause neuropathies including spinal muscular atrophy and Charcot-Marie-Tooth disease. We recently identified MORC2 as an effector of epigenetic silencing by the human silencing hub (HUSH). Here we report the biochemical and cellular activities of MORC2 variants, alongside crystal structures of wild-type and neuropathic forms of a human MORC2 fragment comprising the GHKL-type ATPase module and CW-type zinc finger. This fragment dimerizes upon binding ATP and contains a hinged, functionally critical coiled-coil insertion absent in other GHKL ATPases. We find that dimerization and DNA binding of the MORC2 ATPase module transduce HUSH-dependent silencing. Disease mutations change the dynamics of dimerization by distinct structural mechanisms: destabilizing the ATPase-CW module, trapping the ATP lid, or perturbing the dimer interface. These defects lead to the modulation of HUSH function, thus providing a molecular basis for understanding MORC2-associated neuropathies.
Insights
Missense mutations in MORC2 cause neuropathies. This study reveals how MORC2 variants disrupt HUSH-mediated epigenetic silencing by altering its dimerization and DNA binding, explaining disease mechanisms.
Area of Science:
- Molecular Biology
- Genetics
- Structural Biology
Background:
- Missense mutations in MORC2 are linked to neuropathies like spinal muscular atrophy and Charcot-Marie-Tooth disease.
- MORC2 functions as an effector in the human silencing hub (HUSH) complex, mediating epigenetic gene silencing.
Purpose of the Study:
- To investigate the biochemical and cellular activities of MORC2 variants.
- To elucidate the structural basis of MORC2 function and disease-associated mutations using crystal structures.
Main Methods:
- Biochemical assays to study MORC2 variant activities.
- Crystal structure determination of wild-type and mutant MORC2 fragments (ATPase module and zinc finger).
- Cellular assays to assess HUSH-dependent silencing modulation.
Main Results:
- The MORC2 ATPase module dimerizes upon ATP binding, facilitated by a unique coiled-coil insertion.
- Dimerization and DNA binding of the MORC2 ATPase module are crucial for HUSH-dependent silencing.
- Disease-associated mutations impair MORC2 dimerization through various structural mechanisms, affecting HUSH function.
Conclusions:
- Structural and biochemical insights into MORC2 function and its role in HUSH-mediated epigenetic silencing.
- Provides a molecular understanding of how MORC2 mutations lead to neuropathies by disrupting silencing pathways.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Inheritance of Chromatin Structures
Viral Mutations

